Given the Indian demographic profile and the current stage of healthcare infrastructure, there is an increasing need of investing in quality healthcare, pharma, and allied industries showing a clear and strong growth visibility for healthcare infrastructure and service providers in the years to come. Also, given the fragmented and regional nature of the current players there is a strong case for consolidation and differentiation in the marketplace.

Our strong domain expertise, synergistic association with healthcare and life sciences focused domestic and cross border investment banks and deep relationships with the investors focused on healthcare and life sciences helps gives it a significant edge to deliver superior value to its clients. The team consists of industry veterans who have successfully effectuated several transactions in this space.

We also have a strategic partnership with Ferghana Partners (, a leading Investment Bank focusing on Healthcare and Chemicals. With a team of 18 senior professionals in London, Boston and New York and strategic partners in China, Israel and Australia, it has excellent global Investment Banking Capabilities. Having closed over 53 transactions aggregating USD 5.8 billion since 2004, Ferghana Partners is led by Bill Kridel.